WHO says trials show malaria and HIV drugs don't cut Covid-19 hospital deaths

Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital

The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients in hospital with Covid-19 after they failed to reduce mortality.

The setback came as WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The US accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.

Continue reading...